312-422-1111 ibioadmin@ibio.org

iBIO LEADERSHIP

OUR STAFF

John Conrad

John Conrad

President & CEO

Ann Vogel

Ann Vogel

Senior Vice President, EDUCATE

Monique Naleway

Monique Naleway

Operation Manager, iBIO

BOARD OF DIRECTORS

John Bathery

John Bathery

Vice President, Head of US Business Development, Takeda

Paul Bloom

Paul Bloom

Vice President, Process & Chemical Research, Archer Daniels Midland Company

Vice-Chairman, Food & Agriculture

Steven Ducommun

Steven Ducommun

Partner, Perkins Coie LLP

Corporate Secretary

Drue Duncan

Drue Duncan

Director, Government Relations and Public Affairs, Pfizer

Michael T. Flavin, Ph.D.

Michael T. Flavin, Ph.D.

Managing Director, Flavin Ventures, LLC

David Flowers

David Flowers

Director, Life Sciences Industry, Deloitte

Patrick Gattari

Patrick Gattari

Partner, McDonnell Boehnen Hulbert & Berghoff LLP

MayeBeth Hadfield

MayeBeth Hadfield

Director, State Government Affairs, Genentech, Inc

Member at Large, Executive Committee

Walt Johnston

Walt Johnston

Senior Vice President, Sales & Marketing Urology and Hospital, Astellas Pharma US, Inc.

iBIO Chairman

Gretchen Johnson

Gretchen Johnson

President & CEO, TRACT Therapeutics, Inc.

Member at Large, Executive Committee

Ashish Khanna

Ashish Khanna

Chief Business Officer, Aptinyx, Inc

Blair Komasinski

Blair Komasinski

Assurance Partner, Ernst & Young LLP

Treasurer, Chair-Finance Committee

John Larson

John Larson

General Manager, Alliance Management, AbbVie

Vice-Chair, Human Health

Dan Lyne

Dan Lyne

Senior Vice President, Global Technology & Media, CBRE

Brian McCarthy

Brian McCarthy

Vice President, Managed Markets, Lundbeck

Salim Mujais

Salim Mujais

Senior Vice President, Therapeutic Area Head, Astellas Pharma

Dr. Norbert Riedel

Dr. Norbert Riedel

President & CEO, Aptinyx

Member at Large, Executive Committee

Charlie Tobler

Charlie Tobler

Executive Vice President, Commercial Operations, Tersera

Marilyn Vetter

Marilyn Vetter

Vice President, Government & Public Affairs, Horizon Therapeutics

Timothy P. Walbert

Timothy P. Walbert

Chairman, President & CEO, Horizon Therapeutics

Immediate Past Chair

James White

James White

Divisional Vice President, Global Marketing, Abbott

X